Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma

PD-1 blocks lytic granule polarization with concomitant impairment of integrin outside-in signaling in the natural killer cell immunological synapse

(2018) Yu Huang et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

HIGH RESPONSE RATES WITH PEMBROLIZUMAB IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: INTERIM RESULTS OF AN ON OPEN-LABEL, PHASE II STUDY

(2017) L.J. Nastoupil et al.   HEMATOLOGICAL ONCOLOGY

3D microvascular model recapitulates the diffuse large B-cell lymphoma tumor microenvironment in vitro

(2017) Robert G. Mannino et al.   LAB ON A CHIP

Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies

(2017) Pauline Gravelle et al.   Oncotarget

Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays

(2017) Marie Tosolini et al.   OncoImmunology

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

(2016) S. H. Swerdlow et al.   BLOOD

The emerging role of immune checkpoint inhibition in malignant lymphoma

(2016) Ida Hude et al.   HAEMATOLOGICA

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

(2016) Alexander M. Lesokhin et al.   JOURNAL OF CLINICAL ONCOLOGY

Immuno-engineered organoids for regulating the kinetics of B-cell development and antibody production

(2016) Alberto Purwada et al.   Nature Protocols

PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomas

(2016) Aaron Goodman et al.   Nature Reviews Clinical Oncology

The emerging role of immune checkpoint inhibition in malignant lymphoma

(2016) Ida Hude et al.   HAEMATOLOGICA

Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas

(2016) Marie Tosolini et al.   OncoImmunology

γδ T cell-based anticancer immunotherapy: progress and possibilities

(2015) Serena Meraviglia et al.   Immunotherapy

The prognostic landscape of genes and infiltrating immune cells across human cancers

(2015) Andrew J Gentles et al.   NATURE MEDICINE

Robust enumeration of cell subsets from tissue expression profiles

(2015) Aaron M Newman et al.   NATURE METHODS

Several immune escape patterns in non-Hodgkin's lymphomas

(2015) Camille Laurent et al.   OncoImmunology

A Randomized Phase II Presurgical Trial of Transdermal 4-Hydroxytamoxifen Gel versus Oral Tamoxifen in Women with Ductal Carcinoma In Situ of the Breast

(2014) O. Lee et al.   CLINICAL CANCER RESEARCH

Cell Growth in Aggregates Determines Gene Expression, Proliferation, Survival, Chemoresistance, and Sensitivity to Immune Effectors in Follicular Lymphoma

(2013) Pauline Gravelle et al.   AMERICAN JOURNAL OF PATHOLOGY

Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma

(2013) M. Brodtkorb et al.   BLOOD

Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma

(2013) M. R. Green et al.   BLOOD

High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells

(2013) J. H. Myklebust et al.   BLOOD

Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor V  2 T lymphocytes in non-Hodgkin lymphomas

(2013) A. Musso et al.   HAEMATOLOGICA

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

(2013) Charles Butts et al.   LANCET ONCOLOGY

The yin and the yang of follicular lymphoma cell niches: Role of microenvironment heterogeneity and plasticity

(2013) Patricia Amé-Thomas et al.   SEMINARS IN CANCER BIOLOGY

Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model

(2013) E Decaup et al.   Blood Cancer Journal

What lessons can be learned from γδ T cell-based cancer immunotherapy trials?

(2012) Jean-Jacques Fournié et al.   Cellular & Molecular Immunology

An Integrated Genomic and Expression Analysis of 7q Deletion in Splenic Marginal Zone Lymphoma

(2012) A. James Watkins et al.   PLoS One

Innate predisposition to immune escape in follicular lymphoma cells

(2012) Pauline Gravelle et al.   OncoImmunology

Stimulated    T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer

(2011) A.-H. Capietto et al.   JOURNAL OF IMMUNOLOGY

Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity

(2010) E. Mossner et al.   BLOOD

Functional impact of PTP1B-mediated Src regulation on oxidative phosphorylation in rat brain mitochondria

(2010) Etienne Hébert Chatelain et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens

(2010) Masashi Iwasaki et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

   T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody

(2010) M. S. Braza et al.   HAEMATOLOGICA

C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function

(2009) F. Bossi et al.   BLOOD

High Numbers of Tumor-Infiltrating Programmed Cell Death 1–Positive Regulatory Lymphocytes Are Associated With Improved Overall Survival in Follicular Lymphoma

(2009) Joaquim Carreras et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20

(2008) D. Dayde et al.   BLOOD